ClinicalTrials.gg
CompletedNCT06744452Updated Mar 24, 2026

App-based Stress Management With the mHealth Application "Harmony"

An interventional study of harmony in Stress, Self Efficacy and Resilience, Psychological, sponsored by University of Witten/Herdecke. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-24.

Sponsored by University of Witten/Herdecke · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
251
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to investigate the efficacy of app-based stress prevention via the harmony application in a prospective, interventive, monocentric, explanatory pilot randomized controlled trial (RCT), with participants' subjective stress experience as the primary endpoint.

Research question: Does usage of the app harmony have a positive impact on the subjective experience of stress of its users? Do usage frequency, intensity or width of content engagement influence the efficacy of the intervention?

Hypothesis: We expect improvement of participants' subjective stress experience, stress-related symptoms, subjective well-being, resilient coping, self-efficacy, life satisfaction and goal-attainment.

02

Conditions studied

  • Stress
  • Self Efficacy
  • Resilience, Psychological
  • Goal Achievement
  • Well-Being, Psychological

Keywords

  • Stress management
  • Stress prevention
  • Application
  • App-based prevention
03

In context

Psychological Well-Being

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's enrollment of 251 is above the median of 110 across 1,796 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

University of Witten/Herdecke is the lead sponsor of 40 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Increased stress level (PSS-10 >= 19; corresponds to one standard deviation (SD 6.42)) above the mean (PSS-10 = 12.57) in a representative sample of the German population (Klein et al., 2016)
  • Fulfillment of technical minimum requirements (internet and smartphone access with suitable operating systems)
  • German language skills at a native level or the ability to use the language at at least B level
  • Written to participate in the study after being informed about the study

Exclusion Criteria:

  • Inclusion criteria not met.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
251 participants (actual)

Study arms

  • Experimental
    App-usage across a 12 week time period

    Use of the harmony application, with 6- and 12-week follow-up. Measurements will be taken at baseline as well as at 6- and 12-week follow-up.

    Behavioral: harmony

  • No intervention
    Waitlist-control group

    Use of the harmony application after a 12-week waiting period. Measurements will be taken at baseline as well as at 6- and 12-week follow-up.

Interventions

  • Behavioralharmony

    Use of the app-based digital self-help intervention harmony over a 12-week-period. The app was designed for stress management and the preventive promotion of mental health. Harmony provides users with access to a wide range of psychological self-help content, including video episodes, audio sessions, texts, and downloadable materials. Utilizing artificial intelligence, Harmony offers personalized content suggestions tailored to the user's individual situation and preferences, ensuring the content remains relevant and updated. Content is delivered through a combination of psychoeducation, guided exercises, relaxation techniques, meditations, practical tasks, self-reflection activities, and everyday application tasks.

06

What researchers measure

Primary outcomes

  1. Change from baseline stress at 6 weeks and 12 months

    Perceived Stress Scale (PSS-10, Cohen et al., 1983): Self-report measure to assess psychological stress levels; Likert scale: 1 = never, 5 = very often.

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

  2. Change from baseline stress symptoms at 6 weeks and 12 months

    Stress and Coping Inventory (SCI; Satow, 2024): Self-report measure to assess psychological and physical stress symptoms; Likert scale: 1 = completely true (negative), 4 = not true at all (positive)

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

Secondary outcomes

  1. Subjective well-being

    WHO-5 Well-Being Index (WHO-5; WHO, 1998): Self-report measure to assess subjective well-being. Likert scale from 0 = at no time to 5 = all of the time.

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

  2. Resilient coping

    Brief resilient coping scale (BRCS; Kocalevent et al., 2014): Self-report measure to assess an individual's ability to cope with stress in a resilient manner. Likert scale from 1 = describes me not at all to 5 = describes me very well.

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

  3. Self-efficacy

    General Self-Efficacy Scale (GSE-SI; Di et al., 2023): One-item self-report measure to assess an individual's belief in their ability to perform tasks and handle situations effectively across a variety of contexts.

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

  4. Life satisfaction

    Life Satisfaction Scale (L-1; Beierlein et al., 2015): One-item self-report measure to assess a person's subjective evaluation of their quality of life. Likert scale from 1 = not satisfied at all to 11 = completely satisfied.

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

  5. Goal Attainment

    Goal Attainment Scaling (GAS; Grosse Holtforth \& Grawe, 2002): Self-report measure to assess participants' previously set goals and their achievement; Scale from 0% to 100% in steps of 10%

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

  6. Experience in Social Systems (EXIS; Hunger et al., 2017)

    Self-report measure to assess systemic functioning in private and organizational social systems; Likert scale: 1 = not at all (negative), 6 = fully (positive)

    Time frame: Baseline, 6-week follow-up, 12-week follow-up

Other outcomes

  1. Frequency of application use

    Participants' self report on absolut app usage over the past 6 weeks in days.

    Time frame: 6-week follow-up, 12-week follow-up (experiment group only)

  2. Duration of application use

    Participants' self report on average app usage in minutes per session.

    Time frame: 6-week follow-up, 12-week follow-up (experiment group only)

  3. Extent of application use

    Participants' self report on the extent of usage of different features within the app over the past six weeks. Respondents are asked to indicate which of the following functions they have used: Video, meditation, resilience course, texts, downloadable materials, and mental health checkup. Additionally, respondents specify the frequency of usage for each function.

    Time frame: 6-week follow-up, 12-week follow-up (experiment group only)

  4. User experience

    Participants' self-report on overall impressions of the app. Likert scale from 1 = don't agree at all to 5 = completely agree

    Time frame: 6-week follow-up, 12-week follow-up (experiment group only)

  5. User satisfaction

    Participants' self report on overall satisfaction with their experience using the app. Likert scale from 1 = very bad to 5 = very good

    Time frame: 6-week follow-up, 12-week follow-up (experiment group only)

07

Study locations

1 site
  • Witten/Herdecke University
    Witten, North Rhine-Westphalia 58455, Germany
08

References and documents

Publications

  • Apolinario-Hagen J, Hennemann S, Fritsche L, Druge M, Breil B. Determinant Factors of Public Acceptance of Stress Management Apps: Survey Study. JMIR Ment Health. 2019 Nov 7;6(11):e15373. doi: 10.2196/15373. PubMed 31697243 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in Mar 2025, 3 months.

Of 1,259 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's 3 months is below that.

Counting every sponsor, half of 1,302 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2024
First posted
Dec 20, 2024
StartActual
Nov 25, 2024
Primary completionActual
Mar 3, 2025
CompletionActual
Mar 3, 2025
Last update
Mar 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06744452
Lead sponsor
University of Witten/Herdecke
Responsible party
Christina Hunger-Schoppe (Prof. Dr., University of Witten/Herdecke) — Principal investigator
First posted
Dec 20, 2024
Start date
Nov 25, 2024
Primary completion
Mar 3, 2025
Completion
Mar 3, 2025
Last update
Mar 24, 2026

Study contacts

Christina Hunger-Schoppe, Prof. Dr.
study director · University of Witten/Herdecke

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion